Harbour BioMed funding history / development milestones

战略投资,1.05亿美元

2025.03.01, 阿斯利康

IPO上市,

2020.12.01,

A+轮,融资金额未公开

2018.01.23, 鼎晖投资, 尚珹资本

A轮,5000万美元

Note: collected from public online reports, for reference only.

People who follow Harbour BioMed also follow

Harbour BioMed Competitors (Similar Companies)

“Innovative chemical products and services provider in the drug researc”
生物科技/生物工程 细胞培养 生物制药 细胞株构建
“抗衰老及癌症治疗药物研发商”
“致力于提高动物采食量和消化能力”
“Benefit farmers, nourish consumers”
“Provider of overall solutions for the global wedding industry”
新媒体 软件 舆情服务 媒体
“让文化照明,添彩美丽中国。”
“创新药物研发企业”
“Professional manufacturer of precision multi-position progressive dies”
“To produce more affordable and effective medicines for the Chinese peo”
制药/药业 医药 医药中间体 原料药
“Committed to improving medical quality”
生产 煤电 超低排放 火电
“Focusing on the pharmaceutical and health industry”